Amoksiklav

Medicinal product

(Invented) name

Amoksiklav

Active substance (s)

Amoksicilinas/Klavulano rūgštis

Strength

875 mg/125 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR02, Amoxicillin and beta-lactamase inhibitor

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2020-05-27

Date of renewal

Documents

1306_Amoksiklav_2024-06-17_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

tabletėje yra	1 vnt.
Amoksicilinas	875 mg
Klavulano rūgštis	125 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104210	90314	1090314	lizdinė plokštelė	N14		Receptinis	LT/L/20/1306/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2020-05-27	Registruotas